{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:13:14Z","timestamp":1789985594806,"version":"4.0.1"},"reference-count":46,"publisher":"Aging and Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2022]]},"DOI":"10.14336\/ad.2022.0827","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T09:46:33Z","timestamp":1668678393000},"page":"0","source":"Crossref","is-referenced-by-count":11,"title":["Zn-dependent \u03b2-amyloid Aggregation and its Reversal by the Tetrapeptide HAEE"],"prefix":"10.14336","author":[{"given":"Vladimir A.","family":"Mitkevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny P.","family":"Barykin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Eremina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhusita","family":"Pani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Katkova-Zhukotskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Polshakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei A.","family":"Adzhubei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Kozin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Mironov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Makarov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Nudler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2022.0827-1","doi-asserted-by":"crossref","unstructured":"Walsh DM, Selkoe DJ (2020). Amyloid \u03b2-protein and beyond: the path forward in Alzheimer's disease. Curr Opin Neurobiol, 61:116-124.","DOI":"10.1016\/j.conb.2020.02.003"},{"key":"key-10.14336\/AD.2022.0827-2","doi-asserted-by":"crossref","unstructured":"Barykin EP, Mitkevich VA, Kozin SA, Makarov AA (2017). Amyloid \u03b2 modification: a key to the sporadic Alzheimer\u2019s disease? Frontiers in Genetics, 8:58.","DOI":"10.3389\/fgene.2017.00058"},{"key":"key-10.14336\/AD.2022.0827-3","doi-asserted-by":"crossref","unstructured":"Kozin SA, Mitkevich VA, Makarov AA (2016). Amyloid-b containing isoaspartate 7 as potential biomarker and drug target in Alzheimer\u2019s disease. Mendeleev Communications, 26:269-275","DOI":"10.1016\/j.mencom.2016.07.001"},{"key":"key-10.14336\/AD.2022.0827-4","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Perez KA, Lago LC, Klatt S, McLean CA, Birchall IE, et al. (2021). Quantification of N-terminal amyloid-\u03b2 isoforms reveals isomers are the most abundant form of the amyloid-\u03b2 peptide in sporadic Alzheimer's disease. Brain Commun, 3:fcab028.","DOI":"10.1093\/braincomms\/fcab028"},{"key":"key-10.14336\/AD.2022.0827-5","doi-asserted-by":"crossref","unstructured":"Clarke S (2003). Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev, 2:263-285.","DOI":"10.1016\/S1568-1637(03)00011-4"},{"key":"key-10.14336\/AD.2022.0827-6","doi-asserted-by":"crossref","unstructured":"Shimizu T, Matsuoka Y, Shirasawa T (2005). Biological significance of isoaspartate and its repair system. Biol Pharm Bull, 28:1590-1596.","DOI":"10.1248\/bpb.28.1590"},{"key":"key-10.14336\/AD.2022.0827-7","doi-asserted-by":"crossref","unstructured":"Zatsepina OG, Kechko OI, Mitkevich VA, Kozin SA, Yurinskaya MM, Vinokurov MG, et al. (2018). Amyloid-\u03b2 with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation. Sci Rep, 8:3518.","DOI":"10.1038\/s41598-018-21815-x"},{"key":"key-10.14336\/AD.2022.0827-8","doi-asserted-by":"crossref","unstructured":"Gnoth K, Piechotta A, Kleinschmidt M, Konrath S, Schenk M, Taudte N, et al. (2020). Targeting isoaspartate-modified A\u03b2 rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology. Alzheimers Res Ther, 12:149.","DOI":"10.1186\/s13195-020-00719-x"},{"key":"key-10.14336\/AD.2022.0827-9","doi-asserted-by":"crossref","unstructured":"Istrate AN, Kozin SA, Zhokhov SS, Mantsyzov AB, Kechko OI, Pastore A, et al. (2016). Interplay of histidine residues of the Alzheimer's disease Ab peptide governs its Zn-induced oligomerization. Scientific Reports, 6:21734.","DOI":"10.1038\/srep21734"},{"key":"key-10.14336\/AD.2022.0827-10","doi-asserted-by":"crossref","unstructured":"Tsvetkov PO, Popov IA, Nikolaev EN, Archakov AI, Makarov AA, Kozin SA (2008). Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide. Chembiochem, 9:1564-1567.","DOI":"10.1002\/cbic.200700784"},{"key":"key-10.14336\/AD.2022.0827-11","doi-asserted-by":"crossref","unstructured":"Kepp KP (2012). Bioinorganic chemistry of Alzheimer's disease. Chem Rev, 112:5193-5239.","DOI":"10.1021\/cr300009x"},{"key":"key-10.14336\/AD.2022.0827-12","doi-asserted-by":"crossref","unstructured":"Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (2002). Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A, 99:7705-7710.","DOI":"10.1073\/pnas.092034699"},{"key":"key-10.14336\/AD.2022.0827-13","doi-asserted-by":"crossref","unstructured":"Barykin EP, Garifulina AI, Tolstova AP, Anashkina AA, Adzhubei AA, Mezentsev YV, et al. (2020). Tetrapeptide Ac-HAEE-NH(2) Protects \u03b14\u03b22 nAChR from Inhibition by A\u03b2. Int J Mol Sci, 21:6272.","DOI":"10.3390\/ijms21176272"},{"key":"key-10.14336\/AD.2022.0827-14","doi-asserted-by":"crossref","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2:19-25.","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"key-10.14336\/AD.2022.0827-15","doi-asserted-by":"crossref","unstructured":"Barykin EP, Garifulina AI, Kruykova EV, Spirova EN, Anashkina AA, Adzhubei AA, et al. (2019). Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the alpha7 Nicotinic Receptor and Promotes Neurotoxicity. Cells, 8.","DOI":"10.3390\/cells8080771"},{"key":"key-10.14336\/AD.2022.0827-16","doi-asserted-by":"crossref","unstructured":"Del\u03b2Frate G, Nikitin A (2018). Including Electronic Screening in Classical Force Field of Zinc Ion for Biomolecular Simulations. ChemistrySelect, 3:12367-12370.","DOI":"10.1002\/slct.201802864"},{"key":"key-10.14336\/AD.2022.0827-17","doi-asserted-by":"crossref","unstructured":"Macchiagodena M, Pagliai M, Andreini C, Rosato A, Procacci P (2020). Upgraded AMBER Force Field for Zinc-Binding Residues and Ligands for Predicting Structural Properties and Binding Affinities in Zinc-Proteins. ACS Omega, 5:15301-15310.","DOI":"10.1021\/acsomega.0c01337"},{"key":"key-10.14336\/AD.2022.0827-18","doi-asserted-by":"crossref","unstructured":"Brenner S (1974). The genetics of Caenorhabditis elegans. Genetics, 77:71-94.","DOI":"10.1093\/genetics\/77.1.71"},{"key":"key-10.14336\/AD.2022.0827-19","doi-asserted-by":"crossref","unstructured":"Lu X, Zhang Y, Li H, Jin Y, Zhao L, Wang X (2021). Nicotine prevents in vivo A\u03b2 toxicity in Caenorhabditis elegans via SKN-1. Neurosci Lett, 761:136114.","DOI":"10.1016\/j.neulet.2021.136114"},{"key":"key-10.14336\/AD.2022.0827-20","doi-asserted-by":"crossref","unstructured":"Apfeld J, Kenyon C (1999). Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature, 402:804-809.","DOI":"10.1038\/45544"},{"key":"key-10.14336\/AD.2022.0827-21","doi-asserted-by":"crossref","unstructured":"Dillin A, Crawford DK, Kenyon C (2002). Timing requirements for insulin\/IGF-1 signaling in C. elegans. Science, 298:830-834.","DOI":"10.1126\/science.1074240"},{"key":"key-10.14336\/AD.2022.0827-22","doi-asserted-by":"crossref","unstructured":"Gusarov I, Gautier L, Smolentseva O, Shamovsky I, Eremina S, Mironov A, et al. (2013). Bacterial nitric oxide extends the lifespan of C. elegans. Cell, 152:818-830.","DOI":"10.1016\/j.cell.2012.12.043"},{"key":"key-10.14336\/AD.2022.0827-23","doi-asserted-by":"crossref","unstructured":"Kozin SA, Cheglakov IB, Ovsepyan AA, Telegin GB, Tsvetkov PO, Lisitsa AV, et al. (2013). Peripherally Applied Synthetic Peptide isoAsp7-A\u03b2(1-42) Triggers Cerebral \u03b2-Amyloidosis. Neurotoxicity Research, 24:370-376.","DOI":"10.1007\/s12640-013-9399-y"},{"key":"key-10.14336\/AD.2022.0827-24","doi-asserted-by":"crossref","unstructured":"Kulikova AA, Cheglakov IB, Kukharsky MS, Ovchinnikov RK, Kozin SA, Makarov AA (2016). Intracerebral injection of metal-binding domain of A\u03b2 comprising the isomerized Asp7 increases the amyloid burden in transgenic mice. Neurotoxicity Research, 29:551-557.","DOI":"10.1007\/s12640-016-9603-y"},{"key":"key-10.14336\/AD.2022.0827-25","doi-asserted-by":"crossref","unstructured":"Zolotarev YA, Mitkevich VA, Shram SI, Adzhubei AA, Tolstova AP, Talibov OB, et al. (2021). Pharmacokinetics and Molecular Modeling Indicate nAChR\u03b14-Derived Peptide HAEE Goes through the Blood-Brain Barrier. Biomolecules, 11:909.","DOI":"10.3390\/biom11060909"},{"key":"key-10.14336\/AD.2022.0827-26","doi-asserted-by":"crossref","unstructured":"Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, et al. (1994). Rapid induction of Alzheimer A beta amyloid formation by zinc. Science, 265:1464-1467.","DOI":"10.1126\/science.8073293"},{"key":"key-10.14336\/AD.2022.0827-27","doi-asserted-by":"crossref","unstructured":"Tolstova AP, Makarov AA, Adzhubei AA (2021). Zinc Induced A\u03b216 Aggregation Modeled by Molecular Dynamics. International Journal of Molecular Sciences, 22:12161.","DOI":"10.3390\/ijms222212161"},{"key":"key-10.14336\/AD.2022.0827-28","doi-asserted-by":"crossref","unstructured":"McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, et al. (2012). Utility of an improved model of amyloid-beta (A\u03b2\u2081\u208b\u2084\u2082) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol Neurodegener, 7:57.","DOI":"10.1186\/1750-1326-7-57"},{"key":"key-10.14336\/AD.2022.0827-29","doi-asserted-by":"crossref","unstructured":"Ewald CY, Li C (2010). Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system. Brain Struct Funct, 214:263-283.","DOI":"10.1007\/s00429-009-0235-3"},{"key":"key-10.14336\/AD.2022.0827-30","doi-asserted-by":"crossref","unstructured":"Alexander AG, Marfil V, Li C (2014). Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. Front Genet, 5:279.","DOI":"10.3389\/fgene.2014.00279"},{"key":"key-10.14336\/AD.2022.0827-31","doi-asserted-by":"crossref","unstructured":"Chen X, Barclay JW, Burgoyne RD, Morgan A (2015). Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem Cent J, 9:65.","DOI":"10.1186\/s13065-015-0143-y"},{"key":"key-10.14336\/AD.2022.0827-32","unstructured":"Dostal V, Link CD (2010). Assaying \u03b2-amyloid toxicity using a transgenic C. elegans model. J Vis Exp, 44:2252."},{"key":"key-10.14336\/AD.2022.0827-33","doi-asserted-by":"crossref","unstructured":"Diomede L, Romeo M, Cagnotto A, Rossi A, Beeg M, Stravalaci M, et al. (2016). The new \u03b2 amyloid-derived peptide A\u03b21-6A2V-TAT(D) prevents A\u03b2 oligomer formation and protects transgenic C. elegans from A\u03b2 toxicity. Neurobiol Dis, 88:75-84.","DOI":"10.1016\/j.nbd.2016.01.006"},{"key":"key-10.14336\/AD.2022.0827-34","doi-asserted-by":"crossref","unstructured":"Romeo M, Stravalaci M, Beeg M, Rossi A, Fiordaliso F, Corbelli A, et al. (2017). Humanin Specifically Interacts with Amyloid-\u03b2 Oligomers and Counteracts Their in vivo Toxicity. J Alzheimers Dis, 57:857-871.","DOI":"10.3233\/JAD-160951"},{"key":"key-10.14336\/AD.2022.0827-35","doi-asserted-by":"crossref","unstructured":"Xu J, Yuan Y, Zhang R, Song Y, Sui T, Wang J, et al. (2019). A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting A\u03b2(1-42) aggregation. Bioorg Chem, 82:332-339.","DOI":"10.1016\/j.bioorg.2018.10.072"},{"key":"key-10.14336\/AD.2022.0827-36","doi-asserted-by":"crossref","unstructured":"Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, Styren S, et al. (2001). Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging, 22:217-226.","DOI":"10.1016\/S0197-4580(00)00237-2"},{"key":"key-10.14336\/AD.2022.0827-37","doi-asserted-by":"crossref","unstructured":"Fay DS, Fluet A, Johnson CJ, Link CD (1998). In vivo aggregation of beta-amyloid peptide variants. J Neurochem, 71:1616-1625.","DOI":"10.1046\/j.1471-4159.1998.71041616.x"},{"key":"key-10.14336\/AD.2022.0827-38","doi-asserted-by":"crossref","unstructured":"Minniti AN, Rebolledo DL, Grez PM, Fadic R, Aldunate R, Volitakis I, et al. (2009). Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener, 4:2.","DOI":"10.1186\/1750-1326-4-2"},{"key":"key-10.14336\/AD.2022.0827-39","doi-asserted-by":"crossref","unstructured":"Davis DE, Roh HC, Deshmukh K, Bruinsma JJ, Schneider DL, Guthrie J, et al. (2009). The cation diffusion facilitator gene cdf-2 mediates zinc metabolism in Caenorhabditis elegans. Genetics, 182:1015-1033.","DOI":"10.1534\/genetics.109.103614"},{"key":"key-10.14336\/AD.2022.0827-40","doi-asserted-by":"crossref","unstructured":"Roh HC, Collier S, Guthrie J, Robertson JD, Kornfeld K (2012). Lysosome-related organelles in intestinal cells are a zinc storage site in C. elegans. Cell Metab, 15:88-99.","DOI":"10.1016\/j.cmet.2011.12.003"},{"key":"key-10.14336\/AD.2022.0827-41","doi-asserted-by":"crossref","unstructured":"Bourdenx M, Dovero S, Thiolat ML, Bezard E, Dehay B (2017). Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model. Sci Rep, 7:45831.","DOI":"10.1038\/srep45831"},{"key":"key-10.14336\/AD.2022.0827-42","doi-asserted-by":"crossref","unstructured":"De Strooper B, Simons M, Multhaup G, Van Leuven F, Beyreuther K, Dotti CG (1995). Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. Embo j, 14:4932-4938.","DOI":"10.1002\/j.1460-2075.1995.tb00176.x"},{"key":"key-10.14336\/AD.2022.0827-43","doi-asserted-by":"crossref","unstructured":"Edrey YH, Medina DX, Gaczynska M, Osmulski PA, Oddo S, Caccamo A, et al. (2013). Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease. Neurobiol Aging, 34:2352-2360.","DOI":"10.1016\/j.neurobiolaging.2013.03.032"},{"key":"key-10.14336\/AD.2022.0827-44","doi-asserted-by":"crossref","unstructured":"Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH (1988). Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. Embo j, 7:1365-1370.","DOI":"10.1002\/j.1460-2075.1988.tb02952.x"},{"key":"key-10.14336\/AD.2022.0827-45","doi-asserted-by":"crossref","unstructured":"Steffen J, Krohn M, Paarmann K, Schwitlick C, Br\u00fcning T, Marreiros R, et al. (2016). Revisiting rodent models: Octodon degus as Alzheimer's disease model? Acta Neuropathol Commun, 4:91.","DOI":"10.1186\/s40478-016-0363-y"},{"key":"key-10.14336\/AD.2022.0827-46","doi-asserted-by":"crossref","unstructured":"Mattson MP (2004). Pathways towards and away from Alzheimer's disease. Nature, 430:631-639.","DOI":"10.1038\/nature02621"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/1663615683831-1544945235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T10:02:06Z","timestamp":1668679326000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2022.0827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":46,"URL":"https:\/\/doi.org\/10.14336\/ad.2022.0827","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}